317 related articles for article (PubMed ID: 34912550)
81. COVID-19 Vaccine Hesitancy and How to Address It.
Rittle C
Workplace Health Saf; 2022 Feb; 70(2):56-62. PubMed ID: 35073804
[TBL] [Abstract][Full Text] [Related]
82. COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population.
Alabdulla M; Reagu SM; Al-Khal A; Elzain M; Jones RM
Influenza Other Respir Viruses; 2021 May; 15(3):361-370. PubMed ID: 33605010
[TBL] [Abstract][Full Text] [Related]
83. Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review.
Yazdani Y; Pai P; Sayfi S; Mohammadi A; Perdes S; Spitzer D; Fabreau GE; Pottie K
PLoS One; 2024; 19(7):e0292143. PubMed ID: 38968187
[TBL] [Abstract][Full Text] [Related]
84. Communication to promote and support physical distancing for COVID-19 prevention and control.
Ryan RE; Silke C; Parkhill A; Virgona A; Merner B; Hurley S; Walsh L; de Moel-Mandel C; Schonfeld L; Edwards AG; Kaufman J; Cooper A; Chung RKY; Solo K; Hellard M; Di Tanna GL; Pedrana A; Saich F; Hill S
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015144. PubMed ID: 37811673
[TBL] [Abstract][Full Text] [Related]
85. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.
Hong J; Xu XW; Yang J; Zheng J; Dai SM; Zhou J; Zhang QM; Ruan Y; Ling CQ
J Integr Med; 2022 Jan; 20(1):34-44. PubMed ID: 34774463
[TBL] [Abstract][Full Text] [Related]
86. COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey.
Huang Y; Su X; Xiao W; Wang H; Si M; Wang W; Gu X; Ma L; Li L; Zhang S; Yang C; Yu Y; Qiao Y
BMC Infect Dis; 2022 Feb; 22(1):153. PubMed ID: 35164700
[TBL] [Abstract][Full Text] [Related]
87. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Cambon L; Schwarzinger M; Alla F
Vaccine; 2022 Jan; 40(2):178-182. PubMed ID: 34863619
[TBL] [Abstract][Full Text] [Related]
88. COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention.
Kiptoo J; Isiiko J; Yadesa TM; Rhodah T; Alele PE; Mulogo EM
BMC Public Health; 2024 Jan; 24(1):111. PubMed ID: 38184570
[TBL] [Abstract][Full Text] [Related]
89. Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US.
Khairat S; Zou B; Adler-Milstein J
Am J Infect Control; 2022 Mar; 50(3):262-267. PubMed ID: 34995722
[TBL] [Abstract][Full Text] [Related]
90. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic.
Ouyang H; Ma X; Wu X
Hum Vaccin Immunother; 2022 Dec; 18(1):2013694. PubMed ID: 35172676
[TBL] [Abstract][Full Text] [Related]
91. Vaccine hesitancy among healthcare workers in Europe: A qualitative study.
Karafillakis E; Dinca I; Apfel F; Cecconi S; Wűrz A; Takacs J; Suk J; Celentano LP; Kramarz P; Larson HJ
Vaccine; 2016 Sep; 34(41):5013-5020. PubMed ID: 27576074
[TBL] [Abstract][Full Text] [Related]
92. How prevalent is COVID-19 vaccine hesitancy in low-income and middle-income countries and what are the key drivers of hesitancy? Results from 53 countries.
Dayton Eberwein J; Edochie IN; Newhouse D; Cojocaru A; Bopahbe GD; Kakietek JJ; Kim YS; Montes J
BMJ Open; 2023 Nov; 13(11):e069152. PubMed ID: 37931970
[TBL] [Abstract][Full Text] [Related]
93. Misinformation, knowledge and COVID-19 vaccine acceptance: a cross-sectional study among health care workers and the general population in Kampala, Uganda.
Atuheirwe M; Otim R; Male KJ; Ahimbisibwe S; Sackey JD; Sande OJ
BMC Public Health; 2024 Jan; 24(1):203. PubMed ID: 38233776
[TBL] [Abstract][Full Text] [Related]
94. Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan.
Cao A; Ueta M; Uchibori M; Murakami M; Kunishima H; Santosh Kumar R; Prommas P; Tomoi H; Gilmour S; Sakamoto H; Hashizume M; Naito W; Yasutaka T; Maruyama-Sakurai K; Miyata H; Nomura S
Vaccine; 2024 Jun; 42(17):3684-3692. PubMed ID: 38714450
[TBL] [Abstract][Full Text] [Related]
95. COVID-19 Vaccine Acceptance and Hesitancy Among Health Care Workers in Lebanon.
Youssef NJ; Tfaily NK; Moumneh MBM; Boutros CF; Elharake JA; Malik AA; McFadden SM; Galal B; Yildirim I; Khoshnood K; Omer SB; Memish ZA; Dbaibo GS
J Epidemiol Glob Health; 2023 Mar; 13(1):55-66. PubMed ID: 36735184
[TBL] [Abstract][Full Text] [Related]
96. Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: An Umbrella Review.
McCready JL; Nichol B; Steen M; Unsworth J; Comparcini D; Tomietto M
PLoS One; 2023; 18(4):e0280439. PubMed ID: 37043505
[TBL] [Abstract][Full Text] [Related]
97. Adolescents with ADHD are at increased risk for COVID-19 vaccine hesitancy.
Dvorsky MR; Breaux R; Langberg JM; Becker SP
J Psychiatr Res; 2022 Aug; 152():25-30. PubMed ID: 35714550
[TBL] [Abstract][Full Text] [Related]
98. The changing vaccine landscape: rates of COVID-19 vaccine acceptance and hesitancy in young adults during vaccine rollout.
Knight H; Jia R; Ayling K; Blake H; Morling JR; Villalon AM; Corner J; Denning C; Ball J; Bolton K; Figueredo G; Morris D; Tighe P; Vedhara K
Perspect Public Health; 2023 Jul; 143(4):220-224. PubMed ID: 35575215
[TBL] [Abstract][Full Text] [Related]
99. COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries.
Aw J; Seng JJB; Seah SSY; Low LL
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452026
[TBL] [Abstract][Full Text] [Related]
100. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021.
Lazarus JV; Wyka K; White TM; Picchio CA; Rabin K; Ratzan SC; Parsons Leigh J; Hu J; El-Mohandes A
Nat Commun; 2022 Jul; 13(1):3801. PubMed ID: 35778396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
